Bartholomew James Raymond
Known title: SVP - Chamberlain UniversityCIK: 0001722396
Associated companies
Transaction History
| CVSA | ▼ Sell | Tax Withholding | 318 | $13K | 8/26/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 227 | $9K | 8/25/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 4,620 | $184K | 8/24/2022 | View on chart |
| CVSA | ▼ Sell | Open Market | 2,380 | $75K | 5/20/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 410 | $13K | 5/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.